Literature DB >> 31807188

Upregulation of MANCR predicts poor survival in patients with gastric cancer.

Ling Yao1, Jinhua Yan2, Lihong Gan1, Shenan Huang1, Fei Cheng1, Nian Fang1.   

Abstract

A previous study revealed that MANCR (mitotically associated long non-coding RNA) is implicated in breast cancer. The present study investigated the potential role of MANCR in gastric cancer (GC) and revealed that MANCR was upregulated in GC tissues compared with non-cancerous tissues. MANCR expression was not affected by clinical stages and a high MANCR expression level was associated with poor survival time. MicroRNA (miR)-101 was downregulated in cancer tissues compared with non-cancerous tissues and was inversely associated with MANCR expression. MANCR overexpression in GC cell lines in vitro resulted in miR-101 downregulation; however, miR-101 overexpression did not alter MANCR expression. Furthermore, MANCR overexpression promoted, while miR-101 overexpression inhibited GC cell proliferation. In addition, miR-101 overexpression decreased the effect of MANCR overexpression. The results obtained in the present study revealed that MANCR expression was associated with the survival of patients with GC, and MANCR overexpression in vitro may promote GC by downregulating miR-101 and increasing the proliferation of GC cells.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  gastric cancer; microRNA-101; mitotically associated long non-coding RNA

Year:  2019        PMID: 31807188      PMCID: PMC6876288          DOI: 10.3892/ol.2019.11026

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression.

Authors:  Delphine Bernard; Kannanganattu V Prasanth; Vidisha Tripathi; Sabrina Colasse; Tetsuya Nakamura; Zhenyu Xuan; Michael Q Zhang; Frédéric Sedel; Laurent Jourdren; Fanny Coulpier; Antoine Triller; David L Spector; Alain Bessis
Journal:  EMBO J       Date:  2010-08-20       Impact factor: 11.598

Review 2.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

3.  Differences in gastric cancer survival between the U.S. and China.

Authors:  Vivian E Strong; Ai-Wen Wu; Luke V Selby; Mithat Gonen; Meier Hsu; Kyo Young Song; Cho Hyun Park; Daniel G Coit; Jia-Fu Ji; Murray F Brennan
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

Review 4.  lncRNAs and microRNAs with a role in cancer development.

Authors:  Julia Liz; Manel Esteller
Journal:  Biochim Biophys Acta       Date:  2015-07-04

5.  Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance.

Authors:  Shengqian Zhu; Jinqin Mao; Yongfu Shao; Fang Chen; Xiaoqin Zhu; Dingli Xu; Xinjun Zhang; Junming Guo
Journal:  Tumour Biol       Date:  2015-05-14

6.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

7.  Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer.

Authors:  Kirsten M Tracy; Coralee E Tye; Prachi N Ghule; Heidi L H Malaby; Jason Stumpff; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cancer Res       Date:  2018-01-29       Impact factor: 5.852

8.  Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.

Authors:  Xingkang He; Wenrui Wu; Zhenghua Lin; Yue Ding; Jianmin Si; Lei-Min Sun
Journal:  Gastric Cancer       Date:  2017-10-20       Impact factor: 7.370

Review 9.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

10.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08
View more
  5 in total

1.  LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma.

Authors:  Chang Liu; Haifeng Li; Xiaojing Li; Xuejing Zhao; Xia Zhang
Journal:  BMC Pulm Med       Date:  2021-08-21       Impact factor: 3.317

2.  Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease.

Authors:  Mirolyuba Ilieva; James Dao; Henry E Miller; Jens Hedelund Madsen; Alexander J R Bishop; Sakari Kauppinen; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2022-07-22

3.  Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration.

Authors:  Jianfei Tang; Mingyan Bao; Juan Chen; Xin Bin; Xinghuanyu Xu; Xiaodan Fang; Zhangui Tang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

4.  Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.

Authors:  Sheng Xue; Hanxu Guo; Shibo Wei; Yuan Song; Junfeng Huang; Shuo Deng; Qingwen Li; Wenyong Li
Journal:  Transl Androl Urol       Date:  2022-09

5.  An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma.

Authors:  Bing Qi; Han Liu; Qi Zhou; Li Ji; Xueying Shi; Yushan Wei; Yajun Gu; Akio Mizushima; Shilin Xia
Journal:  Aging (Albany NY)       Date:  2021-07-20       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.